Company Filing History:
2 out of 832,912 Years Active: 2024
Title: Innovations by Wenbo Jin in Pharmaceutical Composition
Introduction
Wenbo Jin is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance drug absorption and bioavailability. His work is characterized by a focus on innovative solutions to improve therapeutic efficacy.
Latest Patents
Wenbo Jin holds two patents that showcase his inventive prowess. The first patent is for a hypoglycemic pharmaceutical composition. This composition includes a GLP-1 receptor agonist and a formulation designed to promote small-intestinal absorption. The components of this formulation consist of sodium lauryl sulfate, carbomer, chitosan, and sodium citrate. This innovative approach aims to enhance the absorption of the active ingredient in the small intestine.
The second patent focuses on a composition for improving the bioavailability of drugs. This composition comprises a surfactant, an acrylic polymer, chitin or its derivatives, and a metal ion chelating agent. Research indicates that this formulation can significantly promote the absorption of effective ingredients in the small intestine, thereby improving their bioavailability.
Career Highlights
Wenbo Jin's career is marked by his dedication to pharmaceutical innovation. His patents reflect a deep understanding of drug formulation and the mechanisms that enhance therapeutic outcomes. His work has the potential to impact the treatment of various conditions, particularly those requiring improved drug absorption.
Collaborations
Wenbo Jin collaborates with Jing Zhang, a fellow innovator in the pharmaceutical field. Their partnership exemplifies the collaborative spirit that drives advancements in drug development.
Conclusion
Wenbo Jin's contributions to pharmaceutical compositions demonstrate his commitment to enhancing drug efficacy through innovative formulations. His patents are a testament to his expertise and the potential impact of his work on the pharmaceutical industry.